Rechciński Tomasz, Kurpesa Małgorzata, Trzos Ewa, Krzeminska-Pakuła Maria
Pracownia Elektrokardiologii Nieinwazyjnej, II Katedra i Klinika Kardiologii UM, łodzi.
Pol Arch Med Wewn. 2006 Jun;115(6):520-8.
Melatonin--sleep-inducing remedy was reported to be implicated in "biological clock" of circulatory system. The deficits of this pineal hormone were observed in patients with coronary artery disease (CAD) and those with abnormal circadian pattern of blood pressure (BP). We hypothesize that melatonin supplementation could be beneficial for this group of patients thanks to return from "non-dippers" to physiological "dippers" group, which is characterized by lower rate of left ventricle hypertrophy and/or number of ischemic episodes, in comparison with "non-dippers". The aim of this study was to assess safety and the effects of melatonin treatment in patients with CAD and impaired circadian pattern of BP.
Thirty-nine ambulatory patients (69% males, mean age 61+/-5,0), with CAD confirmed by coronary angiography and with circadian pattern of BP classified in 24 hour ambulatory blood pressure monitoring (ABPM) as "non-dippers" were included into the study. All study participants, apart of previous treatment, started to use 5 mg melatonin before sleep. Control 24h ABPM was performed after 30 days of such cure. The results of both ABPMs were compared using statistical methods.
Melatonin supplementation improved circadian pattern of BP in one third (30,8%) of study group - they were classified in the second ABPM as "dippers". Despite a tendency to increase a day/night difference of average BP for 5,9%--a percentage of patients who remained in the group of "non-dippers" was 46,2%. Unfavourable effect of melatonin treatment was observed in 23% of patients: 15,4%--"extreme-dippers", 7,6% --"reverse-dippers".
Twenty-four hour noninvasive blood pressure monitoring performed before and during melatonin cure is crucial by considering benefits and dangers of this treatment begun in purpose to modify impaired pattern of blood pressure in patients with coronary artery disease.
褪黑素——一种助眠药物,据报道与循环系统的“生物钟”有关。在冠状动脉疾病(CAD)患者以及血压昼夜节律异常的患者中观察到了这种松果体激素的缺乏。我们推测,补充褪黑素可能对这组患者有益,因为与“非勺型”患者相比,从“非勺型”转变为生理“勺型”组,其左心室肥厚率和/或缺血发作次数较低。本研究的目的是评估褪黑素治疗对CAD患者和血压昼夜节律受损患者的安全性和疗效。
39例门诊患者(69%为男性,平均年龄61±5.0岁),经冠状动脉造影确诊为CAD,且在24小时动态血压监测(ABPM)中血压昼夜节律被分类为“非勺型”,纳入本研究。所有研究参与者,除先前治疗外,开始在睡前服用5毫克褪黑素。在这种治疗30天后进行对照24小时ABPM。使用统计方法比较两次ABPM的结果。
补充褪黑素使研究组三分之一(30.8%)的患者血压昼夜节律得到改善——他们在第二次ABPM中被分类为“勺型”。尽管平均血压的昼夜差异有增加5.9%的趋势,但仍有46.2%的患者留在“非勺型”组。23%的患者观察到褪黑素治疗的不良影响:15.4%为“极端勺型”,7.6%为“反勺型”。
考虑到这种旨在改变冠状动脉疾病患者受损血压模式的治疗的益处和风险,在褪黑素治疗前和治疗期间进行24小时无创血压监测至关重要。